| Willine Louis, APRN, FNP, PMHNP | |
|
980 N Federal Hwy Ste 110, Boca Raton, FL 33432-2704 | |
| (954) 604-2227 | |
| (866) 544-1159 |
| Full Name | Willine Louis |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 980 N Federal Hwy Ste 110, Boca Raton, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013272228 | NPI | - | NPPES |
| 015329100 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | ARNP9202896 (Florida) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | APRN9202896 (Florida) | Primary |
| Entity Name | West Palm Beach Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235231465 PECOS PAC ID: 7618878216 Enrollment ID: O20040116000450 |
News Archive
In a screening for a functional impact to the neuronal differentiation process, Danish researchers identified a specific circular RNA, circZNF827, which surprisingly "taps the brake" on neurogenesis.
Phenex Pharmaceuticals AG announced today the start of a first-in-man Phase I study with its clinical drug candidate Px-102, a synthetic non-steroidal FXR agonist. The volunteers of the first dose level received the drug and showed no signs of discomfort or other adverse effects.
A recent survey conducted by a team of scientists from France reveals that pets living with confirmed coronavirus disease 2019 (COVID-19) patients have a high prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. The study is currently available on the bioRxiv* preprint server.
The Liberal opposition has come up with dismal figures for the July-September period of 2009 related to inadequate emergency services, bed shortages and overflowing emergency departments. According to reports that they obtained under the Freedom of Information, only one in six hospitals had acceptable performance standard for ambulance cases.
› Verified 7 days ago
| Entity Name | Mcr Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255376000 PECOS PAC ID: 7214847995 Enrollment ID: O20040126000213 |
News Archive
In a screening for a functional impact to the neuronal differentiation process, Danish researchers identified a specific circular RNA, circZNF827, which surprisingly "taps the brake" on neurogenesis.
Phenex Pharmaceuticals AG announced today the start of a first-in-man Phase I study with its clinical drug candidate Px-102, a synthetic non-steroidal FXR agonist. The volunteers of the first dose level received the drug and showed no signs of discomfort or other adverse effects.
A recent survey conducted by a team of scientists from France reveals that pets living with confirmed coronavirus disease 2019 (COVID-19) patients have a high prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. The study is currently available on the bioRxiv* preprint server.
The Liberal opposition has come up with dismal figures for the July-September period of 2009 related to inadequate emergency services, bed shortages and overflowing emergency departments. According to reports that they obtained under the Freedom of Information, only one in six hospitals had acceptable performance standard for ambulance cases.
› Verified 7 days ago
| Entity Name | Ehs At Lakeside Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275018673 PECOS PAC ID: 6901146067 Enrollment ID: O20190327002484 |
News Archive
In a screening for a functional impact to the neuronal differentiation process, Danish researchers identified a specific circular RNA, circZNF827, which surprisingly "taps the brake" on neurogenesis.
Phenex Pharmaceuticals AG announced today the start of a first-in-man Phase I study with its clinical drug candidate Px-102, a synthetic non-steroidal FXR agonist. The volunteers of the first dose level received the drug and showed no signs of discomfort or other adverse effects.
A recent survey conducted by a team of scientists from France reveals that pets living with confirmed coronavirus disease 2019 (COVID-19) patients have a high prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. The study is currently available on the bioRxiv* preprint server.
The Liberal opposition has come up with dismal figures for the July-September period of 2009 related to inadequate emergency services, bed shortages and overflowing emergency departments. According to reports that they obtained under the Freedom of Information, only one in six hospitals had acceptable performance standard for ambulance cases.
› Verified 7 days ago
| Entity Name | Grow Healthcare Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245845932 PECOS PAC ID: 3476961368 Enrollment ID: O20210414000053 |
News Archive
In a screening for a functional impact to the neuronal differentiation process, Danish researchers identified a specific circular RNA, circZNF827, which surprisingly "taps the brake" on neurogenesis.
Phenex Pharmaceuticals AG announced today the start of a first-in-man Phase I study with its clinical drug candidate Px-102, a synthetic non-steroidal FXR agonist. The volunteers of the first dose level received the drug and showed no signs of discomfort or other adverse effects.
A recent survey conducted by a team of scientists from France reveals that pets living with confirmed coronavirus disease 2019 (COVID-19) patients have a high prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. The study is currently available on the bioRxiv* preprint server.
The Liberal opposition has come up with dismal figures for the July-September period of 2009 related to inadequate emergency services, bed shortages and overflowing emergency departments. According to reports that they obtained under the Freedom of Information, only one in six hospitals had acceptable performance standard for ambulance cases.
› Verified 7 days ago
| Entity Name | Interstellar Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881333094 PECOS PAC ID: 8527442672 Enrollment ID: O20220908002619 |
News Archive
In a screening for a functional impact to the neuronal differentiation process, Danish researchers identified a specific circular RNA, circZNF827, which surprisingly "taps the brake" on neurogenesis.
Phenex Pharmaceuticals AG announced today the start of a first-in-man Phase I study with its clinical drug candidate Px-102, a synthetic non-steroidal FXR agonist. The volunteers of the first dose level received the drug and showed no signs of discomfort or other adverse effects.
A recent survey conducted by a team of scientists from France reveals that pets living with confirmed coronavirus disease 2019 (COVID-19) patients have a high prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. The study is currently available on the bioRxiv* preprint server.
The Liberal opposition has come up with dismal figures for the July-September period of 2009 related to inadequate emergency services, bed shortages and overflowing emergency departments. According to reports that they obtained under the Freedom of Information, only one in six hospitals had acceptable performance standard for ambulance cases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Willine Louis, APRN, FNP, PMHNP 9374 Aegean Dr, Boca Raton, FL 33496-6681 Ph: (954) 604-2227 | Willine Louis, APRN, FNP, PMHNP 980 N Federal Hwy Ste 110, Boca Raton, FL 33432-2704 Ph: (954) 604-2227 |
News Archive
In a screening for a functional impact to the neuronal differentiation process, Danish researchers identified a specific circular RNA, circZNF827, which surprisingly "taps the brake" on neurogenesis.
Phenex Pharmaceuticals AG announced today the start of a first-in-man Phase I study with its clinical drug candidate Px-102, a synthetic non-steroidal FXR agonist. The volunteers of the first dose level received the drug and showed no signs of discomfort or other adverse effects.
A recent survey conducted by a team of scientists from France reveals that pets living with confirmed coronavirus disease 2019 (COVID-19) patients have a high prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies. The study is currently available on the bioRxiv* preprint server.
The Liberal opposition has come up with dismal figures for the July-September period of 2009 related to inadequate emergency services, bed shortages and overflowing emergency departments. According to reports that they obtained under the Freedom of Information, only one in six hospitals had acceptable performance standard for ambulance cases.
› Verified 7 days ago
Mrs. Eugenia Leontina Mckelvin, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 5529 N Military Trl Apt 1508, Boca Raton, FL 33496 Phone: 240-419-8750 | |
Carissa M Raver, APRN, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 Nw 28th St Ste B1, Boca Raton, FL 33431 Phone: 860-713-8875 | |
Ms. Maria Nichole Thomas, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6651 N Military Trl, Boca Raton, FL 33496 Phone: 561-998-3747 Fax: 561-998-3797 | |
Crystal Lynn Hummel, MSN, ARNP, AGACNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 670 Glades Rd Ste 310, Boca Raton, FL 33431 Phone: 561-955-6631 | |
Claudine Colin, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9937 Floral Park Ln, Boca Raton, FL 33428 Phone: 561-293-9820 | |
Mrs. Johanna Preisler, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 875 Meadows Rd, Boca Raton, FL 33486 Phone: 561-788-7545 |